Songling H. Zhang

Changchun, CN 
Changchun, CN 

Overview

Songling Zhang practices practicing medicine in Changchun, China.

Their clinical expertise encompasses Ovarian Cancer, Tubal Disease, Vaginal Yeast Infection, Vulvovaginitis, and Tissue Biopsy.

They are actively involved in clinical research, co-authoring 63 peer reviewed articles and participating in 2 clinical trials.

Locations

Changchun, China
Other Locations
Jilin, 130061, China
Shandong Provincial Center For Disease Control And Prevention/Shandong Institute Of Preventive Medicine/Shandong Provincial Key Laboratory Of Intelligent Monitoring, Jinan, 250014, China
Weihai, 264299, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Trial of Maintenance Treatment With BGB-290 Versus Placebo in Patients With Platinum-sensitive Recurrent Ovarian Cancer
A Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Trial of Maintenance Treatment With BGB-290 Versus Placebo in Patients With Platinum-sensitive Recurrent Ovarian Cancer
Enrollment Status: Active_not_recruiting
Publish Date: March 16, 2026
Intervention Type: Drug
Study Drug: Pamiparib
Study Phase: Phase 3
An Open Label, Multi-Center Phase I/II Study to Evaluate Efficacy and Safety of BGB-290 in Chinese Subjects With Advanced Ovarian Cancer, Fallopian Cancer, and Primary Peritoneal Cancer or Advanced Triple Negative Breast Cancer
An Open Label, Multi-Center Phase I/II Study to Evaluate Efficacy and Safety of BGB-290 in Chinese Subjects With Advanced Ovarian Cancer, Fallopian Cancer, and Primary Peritoneal Cancer or Advanced Triple Negative Breast Cancer
Enrollment Status: Completed
Publish Date: February 04, 2025
Intervention Type: Drug
Study Drug: Pamiparib
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

63 Total Publications

AI-assisted case-based learning and flipped classroom to improve clinical decision-making: a randomized controlled trial in reproductive medicine.
AI-assisted case-based learning and flipped classroom to improve clinical decision-making: a randomized controlled trial in reproductive medicine.
Journal: Medical education online
Published: May 27, 2026

Frequently Asked Questions about Songling H. Zhang

Is Songling H. Zhang a top-rated expert for Ovarian Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Songling H. Zhang is classified as an Experienced expert for Ovarian Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Songling H. Zhang participate in research or clinical trials?

Yes. Songling H. Zhang has published 63 articles and abstracts on conditions like Ovarian Cancer. You can view a list of Songling H. Zhang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zhang's expertise for a condition
ConditionClose
        View All 17 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile